Our company produces the world’s first six-fold transgenic cloned AD pigs that co-express the APP, TAU and PS1 genes. Compared to mouse models, it is possible to obtain results that are much more similar to humans in the pre-clinical efficacy tests of candidate drugs for AD. The results obtained are the most similar to human trials for these candidate drugs.
If you would like to test the efficacy of a candidate substance at the cellular level, please request a research purpose cell line.